Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Edouard Auclin

Showing results (1-10 of 88) with videos related to

Pageof 9
Sort By:
Bulletin Du Cancer|November 25, 2014
[Head and neck cancers in HIV patients]Edouard Auclin, Laurent Quéro
Cancer Treatment Reviews|March 9, 2019
Refining adjuvant therapy for non-metastatic colon cancer, new standards and perspectivesJulien Taieb, Thierry André, Edouard Auclin
Cancers|July 24, 2021
Comment on Hopkins et al. Value of the Lung Immune Prognostic Index in Patients with Non-Small Cell Lung Cancer Initiating First-Line Atezolizumab Combination Therapy: Subgroup Analysis of the IMPOWER150 Trial. <i>Cancers</i> 2021, <i>13</i>, 1176Edouard Auclin, Laura Mezquita, Benjamin Besse
Bulletin Du Cancer|May 15, 2026
Radon and lung cancerEdouard Auclin, Maxime Janin, Laura Mezquita, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 13, 2017
Clinical and Translational Implications of RET Rearrangements in Non-Small Cell Lung CancerRoberto Ferrara, Nathalie Auger, Edouard Auclin, et al.
Cancer Treatment Reviews|September 11, 2017
Immunosenescence and immunecheckpoint inhibitors in non-small cell lung cancer patients: Does age really matter?Roberto Ferrara, Laura Mezquita, Edouard Auclin, et al.
Clinics and Research in Hepatology and Gastroenterology|July 7, 2012
An unusual recurrence site for HCC!Edouard Auclin, Cécile Camiliéri, Olivier Dubreuil, et al.
European Radiology|March 19, 2022
Validation of a deep learning segmentation algorithm to quantify the skeletal muscle index and sarcopenia in metastatic renal carcinomaVictoire Roblot, Yann Giret, Sarah Mezghani, et al.
Cancers|October 14, 2022
Change of the Neutrophil-to-Lymphocyte Ratio during Treatment: A Potential Prognostic Biomarker in Metastatic Prostate Cancer Treated with Radium-223 DichlorideKevin Kaulanjan, Johanna Dahan, Cédric Charrois-Durand, et al.
The Oncologist|July 16, 2024
A novel risk classification model integrating CEA, ctDNA, and pTN stage for stage 3 colon cancer: a post hoc analysis of the IDEA-France trialThomas Samaille, Antoine Falcoz, Romain Cohen, et al.
Pageof 9

Showing results (1-10 of 88) with videos related to

Sort By:
Pageof 9
Bulletin Du Cancer|November 25, 2014
[Head and neck cancers in HIV patients]Edouard Auclin, Laurent Quéro
Cancer Treatment Reviews|March 9, 2019
Refining adjuvant therapy for non-metastatic colon cancer, new standards and perspectivesJulien Taieb, Thierry André, Edouard Auclin
Cancers|July 24, 2021
Comment on Hopkins et al. Value of the Lung Immune Prognostic Index in Patients with Non-Small Cell Lung Cancer Initiating First-Line Atezolizumab Combination Therapy: Subgroup Analysis of the IMPOWER150 Trial. <i>Cancers</i> 2021, <i>13</i>, 1176Edouard Auclin, Laura Mezquita, Benjamin Besse
Bulletin Du Cancer|May 15, 2026
Radon and lung cancerEdouard Auclin, Maxime Janin, Laura Mezquita, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 13, 2017
Clinical and Translational Implications of RET Rearrangements in Non-Small Cell Lung CancerRoberto Ferrara, Nathalie Auger, Edouard Auclin, et al.
Cancer Treatment Reviews|September 11, 2017
Immunosenescence and immunecheckpoint inhibitors in non-small cell lung cancer patients: Does age really matter?Roberto Ferrara, Laura Mezquita, Edouard Auclin, et al.
Clinics and Research in Hepatology and Gastroenterology|July 7, 2012
An unusual recurrence site for HCC!Edouard Auclin, Cécile Camiliéri, Olivier Dubreuil, et al.
European Radiology|March 19, 2022
Validation of a deep learning segmentation algorithm to quantify the skeletal muscle index and sarcopenia in metastatic renal carcinomaVictoire Roblot, Yann Giret, Sarah Mezghani, et al.
Cancers|October 14, 2022
Change of the Neutrophil-to-Lymphocyte Ratio during Treatment: A Potential Prognostic Biomarker in Metastatic Prostate Cancer Treated with Radium-223 DichlorideKevin Kaulanjan, Johanna Dahan, Cédric Charrois-Durand, et al.
The Oncologist|July 16, 2024
A novel risk classification model integrating CEA, ctDNA, and pTN stage for stage 3 colon cancer: a post hoc analysis of the IDEA-France trialThomas Samaille, Antoine Falcoz, Romain Cohen, et al.
Pageof 9